DOCSLIB.ORG

Faculty List.Indd

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Faculty List.Indd NEW CHALLENGES IN DIAGNOSIS AND TREATMENT OF LIVER DISEASE אתגריםחדשיםבאבחוןוטיפולבמחלותכבד Jerusalem, January 30-31, 2013 Venue: Hadassah Hospital, Ein-Kerem, Jerusalem FACULTY Prof. Harvey Alter Prof. Massimo Colombo Prof. Yaron Ilan Distinguished NIH Investigator. Chairman, 1st Division of Head, Internal Medicine A Chief, Clinical Studies. Gastroenterology, University of Milan, Dept. of Medicine and Liver Unit, Associate Director of Research IRCCS, Maggiore Hospital, Hadassah Medical Center, Jerusalem NIH Department of Transfusion Division of Gastroenterology 1 ISRAEL Medicine Clinical Center Milano, ITALY Bethesda, MD, USA Dr. Izhar Levy Prof. Scott Friedman Liver Unit , Prof. Ziv Ben-Ari Dean for Therapeutic Discovery , Institute of Gastroenterology and Liver Director, Liver Disease Center Fishberg Professor of Medicine, Disease Sheba Medical Center, Pharmacology and Systems Dept. of Medicine, Tel-Hashomer, Ramat-Gan, Therapeutics, Hadassah Medical Center, Jerusalem ISRAEL Chief, Division of Liver Diseases ISRAEL Mount Sinai Medical Center, Prof. Andrew Burroughs School of Medicine Prof. Michael Manns Consultant Physician and New York, USA Professor and Chairman Hepatologist Department of Gastroenterology, Royal Free Hospital, Liver Prof. Eithan Galun Hepatology and Endocrinology Transplantation Director, Goldyne Savad Institute of Hannover, GERMANY and Hepatobiliary Medicine Gene Therapy London, UNITED KINGDOM Hadassah-Hebrew University Hospital, Jerusalem, ISRAEL Prof. Ran Oren Prof. David Shafritz Prof. Ran Tur-Kaspa Director, Institute of Gastroenterology Director, Liver Research Center Head, Dept. of Internal Medicine and Liver Disease Albert Einstein College of Medicine, & Liver Institute Dept. of Medicine, Liver Research Center Rabin Medical Center, Hadassah Medical Center, Jerusalem Bronx, NY, USA Petach-Tiquva ISRAEL ISRAEL Dr. Oren Shibolet Prof. Dominique Valla Prof. Jean Michel Pawlotzky Director Liver Unit INSERM Chief Virology Unit Dept of Gastroenterology Hospital Beaujon, Universite Paris Universite Paris XII, Tel Aviv Medical Center, FRANCE Hopital Henri Mondor ISRAEL Paris, FRANCE Dr. Vered Yahalom Prof. Daniel Shouval Magen David Adom, Prof. Shimon Reif Liver Unit National Blood Bank Services Head, Department of Pediatrics Institute of Gastroenterology and Liver Tel-Hashomer, Ramat-Gan Hadassah Medical Center, Jerusalem Disease ISRAEL ISRAEL Dept. of Medicine Hadassah-Hebrew University Hospital Prof. Rifaat Safadi Jerusalem, ISRAEL CHAIRMEN/CHAIRWOMEN Director, Liver Unit Saif Abu-Mouch, Israel Institute of Gastroenterology and Prof. Norrah Terrault Allan Bloom, Israel Hepatology and Liver Disease Professor of Medicine and Surgery, Andrew Burroughs, United Kingdom Dept. of Medicine Director of the Viral Hepatitis Center, Michal Carmiel, Israel Hadassah Medical Center, Jerusalem University of California, San Francisco Massimo Colombo, Italy ISRAEL USA Scott Friedman, United States Yaron Ilan, Israel Prof. Didier Samuel Prof. Mark Thursz Michael Manns, Germany Head Liver Unit and Liver ICU, Secretary of the European Association Assy Nimmer, Israel Medical Director Liver Transplant for the Study of the Liver, Orit Pappo, Israel Program, Faculty of Medicine, Imperial College Jean Michel Pawlotzky, France Editor, Journal of Hepatology , St Mary’s Campus, Norfolk Place Didier Samuel, France Hopital Paul Brousse London, UNITED KINGDOM Paris, FRANCE החברההמארגנת:רחובנירים1,ביתקנדה,ת“ד9352,תלאביב6109202 ההרשמהבאמצעותאתרההרשמהhttp://www.events.ortra.com/etgarim2013אוטופסהרשמהבפקס טלפון:03-6384444,פקס:03-6384455 .
Load more

Recommended publications
  • Scientific Program
    www.iscort.org.il Scientific Program 08.01.2019 - 12.01.2019, Eilat, Israel The Annual Meeting of The Israeli Society for Clinical Oncology and Radiation Therapy ISCORT wishes to express its gratitude to the following companies הוועדה המארגנת for their support of the 19th ISCORT Annual Meeting: Organizing Committee ISCORT 19 נשיא הכנס: :President פרופ׳ סלומון שטמר Platinum Sponsor Salomon M. Stemmer, MD Roche מזכירת הכנס: :Secretory ד״ר ולריה סמניסטי Gold Sponsor Valeria Semenysty, MD יו"ר הרדיותרפיה: :BMS Radiation Oncology Co-Chair פרופ׳ בן קורן MSD Ben W. Corn, MD הוועדה המדעית Silver Sponsor Scientific Committee ISCORT 19 Astellas יו"ר: פרופ׳ מיכל לוטם Astrazeneca Chairman: Michal Lotem, MD ד"ר אהרון אלון Boehringer Ingelheim Aaron Allen, MD ד"ר נועם אסנה Eli Lilly Noam Asna, MD ד"ר יאיר בר ISI Jair Bar, MD PhD ד"ר יהונתן כהן Novartis Yonathan Cohen, MD PhD פרופ׳ בן קורן Pfizer Ben W. Corn, MD ד"ר אלה עברון Rafa Ella Evron, MD ד"ר דניאלה כץ Daniela Katz, MD פרופ׳ גל מרקל Bronze Sponsor Gal Markel, MD PhD ד"ר אינה אוספובט AbbVie Inna Ospovat, MD ד"ר אביבית פאר Assuta Avivit Peer, MD ד"ר רות פרץ Bayer Ruth Perets, MD PhD Bolpharma ד"ר רפאל פפר Raphael Pfeffer, MD Dexcel Pharma ד"ר קרן רובינוב Keren Rouvinov, MD Isotopia ד"ר יקטרינה שולמן Katerina Shulman, MD Medison ד"ר אמיר זוננבליק Merck Amir Sonnenblick, MD ד"ר מרק ויגודה Nanostring Marc Wygoda, MD ד"ר אלונה זר Neopharm Alona Zer, MD ד"ר אביעד זיק Oncotest-Teva Aviad Zik, MD Perrigo החברה המארגנת Sanofi Organizing Company א.מ.
    [Show full text]
  • Around the Globe Israeli Medical Association No
    Around The Globe Israeli Medical Association No. 16 | June 2011 A word from the chairman Dear Friends, vices to those from evacuated areas who and opinions on professional issues as e are happy to present you had no access to medical care. well as on the unbalanced exposures and with another issue of ‘IMA I had the pleasure of travelling to discussions of political topics concerning around the Globe’ where the UK, and met our Jewish Medical As- Israel in the British scientific Journals. I Wyou can read about the work of the IMA sociation - UK Chapter. I met medical would like to thank the IMA UK Chapter in Israel and abroad. In February, the students affiliated with the IMA and re- for their generous hospitality during my IMA publically announced our launch viewed Neuroscience practice in Israel. time in London. of “a mission to save public medicine,” I attended an evening event hosted by I am excited to inform you that we demanding additional manpower, more Dr. David Katz, the executive chairman have been invited to present Israeli and beds in hospitals, and incentive pay to of the UK Chapter, which was attended Jewish Medicine at the European Par- draw more physicians to the periphery by the local IMA-WF committee group. liament this November. I would like to and to multiple specialties suffering Throughout the evening we discussed thank Dr. Willie Lipschutz, the executive from physician shortages. This struggle issues related to how Israeli medicine chairman of the Belgian Chapter of IMA- is for health and medicine in Israel and is portrayed in British medical journals, WF for organizing the event.
    [Show full text]
  • Dear Colleagues, It Is Our Pleasure to Invite You to the Annual Meeting Of
    Dear Colleagues, It is our pleasure to invite you to the Annual Meeting of the Israel Neurosurgical Society which will be held at the Galilion Hotel, Israel. Although the main focus of the meeting will be Brain Tumors, the organizers will be happy to consider interesting talks on related subjects. Confirmed speakers to date that will share their experiences and update us in the latest developments include: Prof. Volker A. Coenen Dept. of Stereotactic and Functional Neurosurgery, University of Freiberg; Neurosurgery Clinic, Freiberg, Germany Prof. Garth Rees Cosgrov Dept. of Neurological Surgery, Brigham and Women's Hospital, Boston, MA, USA Prof. Hans Henkes Neuroradiological Clinic, Katharinenhospital, Stuttgart, Germany Prof. Robert H. Rosenwasser Dept. of Neurological Surgery, Jefferson Hospital for Neuroscience, Philadelphia, PA, USA As in previous meetings, we hope that this event will provide the opportunity to reconnect and meet with colleagues and to strengthen professional and personal ties among our members. We hope that you will be able to join us. Sincerely, Prof. Yigal Shoshann Prof. Mony Benifla Dr. Racheli Grossman President Secretary Treasurer 1 TENTATIVE TIMETABLE Wednesday, May 13, 2020 Light Lunch Afternoon Sessions Dinner Evening Social Event Thursday, May 14, 2020 Morning Sessions Lunch Afternoon Sessions Dinner Evening Social Event Friday, May 15, 2020 Morning Sessions Afternoon Sessions End and Light Lunch Meeting Secretariat Target Conferences Ltd. PO Box 51227, Tel Aviv 6713818, Israel Tel: +972 3 5175150, Fax: +972 3 5175155 e-mail: [email protected] www.israelneurosurgery.com 2 SCIENTIFIC ADVISORY COMMITTEE ON FUNCTIONAL NEUROSURGERY AND EPILEPSY Zvi Israel - Lead Advisor Dept. of Neurosurgery, Hadassah Hebrew University Medical Center, Jerusalem Roberto Spiegelmann Dept.
    [Show full text]
  • Silicone Breast Implants and the Risk of Autoimmune/Rheumatic Disorders: a Real-World Analysis
    Silicone breast implants and the risk of autoimmune/rheumatic disorder... 31.08.2020, 07:22 Silicone breast implants and the risk of autoimmune/rheumatic disorders: a real-world analysis Abdulla Watad, Vered Rosenberg, Gabriel Chodick and Howard Amital authors share equal contribution. Article Navigation Abdulla Watad, Department of Medicine ‘B’, Sheba Medical Center, Tel-Hashomer, Israel The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel Search for other works by this author on: Vered Rosenberg, Epidemiology and Database Research, Maccabi Healthcare Services, Tel Aviv, Israel Search for other works by this author on: Shmuel Tiosano, Department of Medicine ‘B’, Sheba Medical Center, Tel-Hashomer, Israel The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel https://academic.oup.com/ije/article/47/6/1846/5133598 1 von 34 Silicone breast implants and the risk of autoimmune/rheumatic disorder... 31.08.2020, 07:22 Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel Search for other works by this author on: Jan Willem Cohen Tervaert, Jan Willem Cohen Tervaert Division of Rheumatology, Department of Medicine and Dentistry, University of Alberta, Edmonton, Canada Department of Medicine and Immunology, University of Maastricht, Maastricht, The Netherlands Search for other works by this author on: Yarden Yavne, Department of Medicine ‘B’, Sheba Medical Center, Tel-Hashomer, Israel The Zabludowicz
    [Show full text]
  • When Are Foreign Volunteers Useful? Israel's Transnational Soldiers in the War of 1948 Re-Examined
    This is a repository copy of When are Foreign Volunteers Useful? Israel's Transnational Soldiers in the War of 1948 Re-examined. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/79021/ Version: WRRO with coversheet Article: Arielli, N (2014) When are Foreign Volunteers Useful? Israel's Transnational Soldiers in the War of 1948 Re-examined. Journal of Military History, 78 (2). pp. 703-724. ISSN 0899- 3718 Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ promoting access to White Rose research papers Universities of Leeds, Sheffield and York http://eprints.whiterose.ac.uk/ White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/79021/ Paper: Arielli, N (2014) When are foreign volunteers useful? Israel's transnational soldiers in the war of 1948 re-examined. Journal of Military History, 78 (2). 703 - 724. White Rose Research Online [email protected] When are Foreign Volunteers Useful? Israel’s Transnational Soldiers in the War of 1948 Re-examined Nir Arielli Abstract The literature on foreign, or “transnational,” war volunteering has fo- cused overwhelmingly on the motivations and experiences of the vol- unteers.
    [Show full text]
  • Scientific Program
    The 63th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery April 12-13 • 2016 • Tel Aviv, Israel SCIENTIFIC PROGRAM Paragon Israel (Dan Knassim) Paragon Tel/Fax:03-5767730/7 Israel (Dan Knassim) a Paragon Group Company [email protected] TUESDAY, APRIL 12, 2016 08:30-10:00 Interventional Cardiology I Hall A Chairs: Ariel Finkelstein, Ran Kornowski, Israel 08:30 Effect of Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes: a propensity score-matched analysis Amos Levi1,2, Tamir Bental1,2, Hana Veknin Assa1,2, Gabriel Greenberg1,2, Eli Lev1,2, Ran Kornowski1,2, Abid Assali1,2 1Cardiology, Rabin Medical Center, Israel 2Sackler Faculty of Medicine, Tel Aviv University, Israel 08:41 Percutaneous Valve-in-Valve Implantation for the Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Degeneration Uri Landes1, Abid Assali1, Ram Sharoni1,2, Hanna Vaknin-Assa1, Katia Orvin1, Amos Levi1, Yaron Shapira1, Shmuel Schwartzenberg1, Ashraf Hamdan1, Tamir Bental1, Alexander Sagie1, Ran Kornowski1 1Department of Cardiology, Rabin Medical Center, Tel Aviv, Israel 2Department of Cardiac Surgery, Rabin Medical Center, Tel Aviv, Israel 08:52 Temporal Trends in Transcatheter Aortic Valve Implantation in Israel 2008-2014: Patient Characteristics, Procedural Issues and Clinical Outcome Uri Landes1, Alon Barsheshet1, Abid Assali1, Hanna Vaknin-Assa1, Israel Barbash3, Victor Guetta3, Amit Segev3, Ariel Finkelstein2, Amir Halkin2, Jeremy Ben-Shoshan2,
    [Show full text]
  • Therapeutic Hypothermia for Comatose Patients: VF Versus Other Initial Rhythm – Does It Matter?
    P13 - Posters - Intensive Cardiac Care Therapeutic Hypothermia for Comatose Patients: VF Versus Other Initial Rhythm – does it Matter? Avishag Laish-Farkash, Shlomi Matetzky, Samer Kassem, Alon Barsheshet, Hanny Haj-Iahia, Nataliya Ulanovsky, Hanoch Hod Heart Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 339 P13 - Posters - Intensive Cardiac Care The Value of Troponin-I Curve after Primary PCI for ST Elevation Myocardial Infarction Avishag Laish-Farkash 1,3, Hanoch Hod 1,3,Ben-Ami Sela2,3,Yoram Amsalem1,3, Athanasios Michailidis 1, Shlomi Matetzky 1,3 1 Heart Institute, 2 Institute for Chemical Pathology, Sheba Medical Center, Tel Hashomer, 3 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 340 P13 - Posters - Intensive Cardiac Care C-Reactive Protein as a Predictor of Active Coronary Disease and Worse Prognosis in Chest Pain Unit Dan Oieru 1,Roy Beigel1, Hanoch Hod 1,2, Pierre Chouraqui 1,2,Orly Goitein1, Eli Konen 1, Roy Beinart 1,Paul Fefer1,Ben-Ami Sela3,Ari Shamiss4,Jacob Or5, Shlomi Matetzky 1,2 1 Heart Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, 2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 3 Biochemical Laboratory, 4 Hospital Director, 5 Emergency Department, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 341 P13 - Posters - Intensive
    [Show full text]
  • Antibiotic Treatment for Invasive Listeriosis and Patient
    Antibiotic treatment for invasive listeriosis and patient outcome: a retrospective cohort study Yaakov Dickstein1, Yonatan Oster2, Orit Shimon3, Lior Nesher4, Dafna Yahav3,5, Yonit Wiener-Well6, Regev Cohen7,8, Ronen Ben-Ami3,9, Miriam Weinberger3,10, Galia Rahav3,11, Yasmin Maor3,12, Michal Chowers3,13, Ran Nir-Paz2, Mical Paul1,8 1 Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel 2 Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 3 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 4 Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheba, Israel 5 Infectious Diseases Unit, Rabin Medical Center, Beilinson hospital, Petah-Tikva, Israel 6 Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel 7 Infectious Diseases Unit, Sanz Medical Center–Laniado Hospital , Netanya, Israel 8 The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 9 Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 10 Infectious Diseases Unit, Assaf Harofeh Medical Center, Zerifin, Israel 11 Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel 12 Infectious Disease Unit, Wolfson Medical Center, Holon, Israel 13 Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel Cumulative survival by treatment group Background: Current treatment started within 48 hours of culture recommendations for treatment of results and continued for a minimum duration invasive listeriosis suggest ampicillin- of 7 days. Patients who died within 48 hours of based therapy with the addition of an the index culture were excluded. The primary aminoglycoside. However, several outcome was 30-day all-cause mortality.
    [Show full text]
  • Mortality of Patients with Rheumatoid Arthritis Requiring Intensive Care: a Single-Center Retrospective Study
    Clinical Rheumatology (2019) 38:3015–3023 https://doi.org/10.1007/s10067-019-04651-w ORIGINAL ARTICLE Mortality of patients with rheumatoid arthritis requiring intensive care: a single-center retrospective study Yael Haviv-Yadid1 & Yulia Segal2 & Amir Dagan3,4,5 & Kassem Sharif6 & Nicola Luigi Bragazzi7 & Abdulla Watad6 & Howard Amital6,8,9 & Yehuda Shoenfeld8,9,10,11 & Ora Shovman6,8,9 Received: 20 February 2019 /Revised: 10 June 2019 /Accepted: 18 June 2019 /Published online: 26 June 2019 # International League of Associations for Rheumatology (ILAR) 2019 Abstract Background Patients with rheumatoid arthritis (RA) are at a high risk for life-threatening conditions requiring admission to the intensive care unit (ICU), but the data regarding the outcomes of these patients is limited. The present study investigated the clinical characteristics and outcomes of RA patients admitted to an ICU. Methods This retrospective cohort study included RA patients admitted to the general ICU of the Sheba Medical Center during 2002–2018. The main outcome was 30-day mortality. Using Student’s t test, χ2, and multivariable analyses, we compared the demographic, clinical, and laboratory parameters of the survivors and the non-survivors. Figures with p value < 0.05 were considered statistically significant. Results Forty-three RA patients were admitted to the ICU during the study period (mean age, 64.0 ± 13.1 years; 74.4% female). The leading causes of ICU admission were infection (72.1%), respiratory failure (72.1%), renal failure (60.5%), and septic shock (55.8%). The 30-day mortality rate was 34.9%, with infection (9/15, 60%) as the most frequent cause.
    [Show full text]
  • APF Newsletter, Winter 2006 – 2007
    Winter 2006-2007 APF A Newsletter of the From The President AmericanEmergency Physicians andFellowship Disaster Preparednessfor Medicine in Israel Course News in Israel From The President Israel in Crisis Mission August 2006 would like to share with our members and donors the important by Dr. Dan Moskowitz I APF activities of the past 6 months. his past August, I had the privilege of being invited to par- 1. APF ISRAEL CRISIS FUND REPORT After placing on our T ticipate in an Emergency APF Mission to Israel with APF website and sending a special crisis appeal from Dr. Danny Laor, Board members Drs. Mike Frogel, Paul Liebman and Charles the Deputy Minister for Emergency Preparedness, on the critical Kurtzer. Dr. Boaz Tadmor organized an incredible, whirlwind needs of the Northern hospitals, it was very gratifying indeed that over $100,000 tour for us, only two days after the cessation of hostilities in was received for our Crisis Fund. All of this will be distributed to hospitals such as Israel. We were provided with a unique glimpse of the Israeli Sieff Hospital in Safed, Poriya in Tiberias, Western Galilee Medical Center in Nahariya, and Rambam Medical Center in Haifa, with the hospital CEO’s given the healthcare system under stress, including face-to-face meet- discretion as to how best to utilize these funds to help their hospital in light of the ings with top healthcare officials, as well as visits to the trau- recent crisis. matized hospitals in northern Israel. Perhaps most importantly, we visited 2. MISSION TO ISRAEL Three APF Board members, Drs.
    [Show full text]
  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
    BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 26, 2021 by guest. Protected copyright. BMJ Open BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from PipEracillin Tazobactam versus mERoPENem for treatment of bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae - a non-inferiority randomized controlled trial (PeterPen) ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2020-040210 Article Type: Protocol Date Submitted
    [Show full text]
  • YEHUDA SHOENFELD, MD, FRCP(Hon.)
    YEHUDA SHOENFELD, M.D., FRCP(Hon.) CURRICULUM VITAE 2013 Chaim Sheba Medical Center The Zabludowicz Center for Autoimmune Diseases Tel Hashomer 52621, Israel Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel-Aviv University, Israel. Tel: 03-5302661 Fax: 03-5352855 E-mail: [email protected] - 2 - CURRICULUM VITAE YEHUDA SHOENFELD, M.D. Date and place of birth: February 14, 1948, Slovakia. Marital Status: Married + 3 (Nettea, Amir, Guy) EDUCATION 1965 - 1972 Hadassa Medical School, Hebrew University, Jerusalem 1972 - M.D. Thesis: "Osteogenesis Imperfecta" (Advisor: Prof. A. Fried) cum laude 1976 - 1978 Diploma cum laude upon completion of post graduate studies in internal medicine, Postgraduate Medical School, Tel Aviv University 1976 - Senior resident, Department of Internal Medicine "D" and Out-Patient Clinic of Hematology and Immunology, Beilinson Medical Center, Petach Tikva, Israel 1978 (3m) - Clinical Fellowship, Hematology/Oncology, Department of Hematology, City of Hope, Duarte, California (Director: Prof. E. Beutler) 1979 (3m) - Clinical Fellowship Hematology/Oncology, Tufts New England Medical Center, Boston, Mass. (Director: Prof. Robert S. Schwartz) 1980 (3m) - Clinical Fellowship Hematology/Oncology, Cornell Medical Center, New York Hospital (Director: Prof. R. Nachman) 1980 - Master in Internal Medicine, Postgraduate Medical School, Tel-Aviv University 1983 - 1984 Senior Physician, department of Internal Medicine "D", Beilinson Medical Center, Petach Tikva, Israel 1985 - Head, Department of Medicine "D" and Outpatient Clinic for Clinical Immunology and Allergy, Soroka Medical Center, Beer-Sheva, Israel 1985 - Head of the Hybridoma Unit and Research Laboratory for Autoimmune Diseases, Soroka Medical Center, and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel 1989 - Head of Department of Medicine "B" Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Israel.
    [Show full text]